P

Inventor

SAHOO SOUMYA P

US33 patents
⚠️ This page may combine multiple inventors who share the name “SAHOO SOUMYA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

28 patents
US6200998B1Mar 13, 2001

Arylthiazolidinedione derivitives

MERCK & CO INC84 citations96
US6645974B2Nov 11, 2003

Androgen receptor modulators and methods for use thereof

MERCK & CO INC63 citations95
US5859051AJan 12, 1999

Antidiabetic agents

MERCK & CO INC150 citations95
US6008237ADec 28, 1999

Arylthiazolidinedione derivatives

MERCK & CO INC57 citations94
US6713508B2Mar 30, 2004

Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders

MERCK & CO INC27 citations92
US5910497AJun 8, 1999

16-pyrazinyl-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors

MERCK & CO INC18 citations92
US5719158AFeb 17, 1998

16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors

MERCK & CO INC22 citations92
US5693809ADec 2, 1997

Substituted 4-aza-5α-androstan-ones as 5α-reductase inhibitors

MERCK & CO INC37 citations92
US6090836AJul 18, 2000

Benzisoxazole-derived antidiabetic compounds

MERCK & CO INC24 citations91
US5591737AJan 7, 1997

Substituted azetidinones as anti-inflammatory and antidegenerative agents

MERCK & CO INC18 citations84
US5739137AApr 14, 1998

16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors

MERCK & CO INC14 citations82
US5001123AMar 19, 1991

2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

MERCK & CO INC20 citations81
US4996203AFeb 26, 1991

2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

MERCK & CO INC20 citations81
US6001844ADec 14, 1999

4-Azasteroids for treatment of hyperandrogenic conditions

MERCK & CO INC12 citations74
US5010100AApr 23, 1991

Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

MERCK & CO INC9 citations74
US6645997B2Nov 11, 2003

Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders

MERCK & CO INC8 citations73
US5763361AJun 9, 1998

17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors

MERCK & CO INC13 citations73
US6399640B1Jun 4, 2002

Arylthiazolidinedione and aryloxazolidinedione derivatives

MERCK & CO INC9 citations72
US7319170B2Jan 15, 2008

N-cyclohexylaminocarbonyl benzensulfonmide derivatives

MERCK & CO INC6 citations63
US5658922AAug 19, 1997

4-aza-pregnane 5α-reductase isozyme 1 inhibitors

MERCK & CO INC3 citations63
US5679700AOct 21, 1997

Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents

MERCK & CO INC5 citations62
US5114961AMay 19, 1992

2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

MERCK & CO INC3 citations61
US6380191B1Apr 30, 2002

Arylthiazolidinedione and aryloxazolidinedione derivatives

MERCK & CO INC3 citations60
US5932551AAug 3, 1999

Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents

MERCK & CO INC6 citations60
USRE39056EApr 4, 2006

4-Azasteroids for treatment of hyperandrogenic conditions

MERCK & CO INC0 citations52
US6204273B1Mar 20, 2001

16-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors

MERCK & CO INC0 citations52
US6143887ANov 7, 2000

Process for the stereoselective synthesis of 16-substituted-4-aza-androstanones

MERCK & CO INC0 citations50
US6465497B2Oct 15, 2002

Arylthiazolidinedione derivatives

MERCK & CO INC1 citations49

MJALLI ADNAN M M

1 patent

TRANSTECH PHARMA LLC

1 patent

KOYAMA HIROO

1 patent

MERCK SHARP & DOHME

1 patent

MERK SHARP & DOHME CORP

1 patent